New Delhi: Drug major Cipla has asked the Narendra Modi government at the Centre to allow price hike of asthma and other respiratory drugs, citing a 300 per cent increase in production cost, News18 has learnt. In a letter written by the Mumbai-based pharma firm to the country’s drug price regulator, National Pharmaceuticals Pricing Authority, the company has highlighted the …
Seeking fast-track approvals to bring Moderna's single-dose COVID-19 booster vaccine in India expeditiously, Cipla has requested the government for indemnification and exemptions from price capping, bridging trials and basic customs duty, while stating that it is close to committing over $1-billion as advance to the US major, sources said on Monday. Requesting the government to provide confirmation on four critical …
Seeking fast-track approvals to bring Moderna’s single-dose COVID-19 booster vaccine in India expeditiously, Cipla has requested the government for indemnification and exemptions from price capping, bridging trials and basic customs duty, while stating that it is close to committing over USD 1-billion as advance to the US major, sources said on Monday. Requesting the government to provide confirmation on four …
)